Current Edition

Drug Patent

4 Drugs Facing Key Patent Expirations and Potential Generic Entry From September 2021–November 2021

A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry. Yali Friedman at DrugPatentWatch presents a set of an …

Continue Reading →
Small Biotechs

Divided by a Common Language: PV Differences Between the UK and the US – Notes for Ambitious Biotechs

In the modern market, small and nimble biotechs possess many great advantages in terms of their ability to bring new innovation to market quickly, unhindered …

Continue Reading →

Suven Life Sciences gets patents in China and US

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences …

Continue Reading →